Chandigarh-based Parabolic Drugs, engaged in manufacturing of active pharmaceutical ingredients intermediates for domestic and international markets, has been granted ‘Certificate of Suitability’ (COS) for its molecule Cefixime in the European Union (EU). COS is recognised by various signatory states of the EU.
Top Section
Explore Business Standard